Effect of Intravenous Dexmedetomidine on Analgesic Duration of Infraclavicular Block
Postoperative Pain
About this trial
This is an interventional treatment trial for Postoperative Pain focused on measuring Dexmedetomidine sedation, Regional Anesthesia, Infraclavicular block
Eligibility Criteria
Inclusion Criteria:
- Male and females of 16-80 years of age, scheduled for hand, forearm and elbow ambulatory surgery with an infraclavicular block.
- American Society of Anesthesiologist (ASA) Class I, II, III
- Ability to cooperate with study related procedures
Exclusion Criteria:
- ASA IV
- Narcotic dependent (opioid intake more than 3 months) or chronic pain conditions
- Associated significant cardiac or respiratory disease, neurological deficits
- Coexisting hematological disorder or with deranged coagulation
- Pre-existing major organ dysfunction
- Psychiatric illnesses
- Emergency surgery
- Lack of informed consent
- Allergy to any of the drugs used in the study
- Surgical procedure duration greater than 3 hours
Sites / Locations
- Saint Joseph's Health Care London
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Propofol sedation.
Dexmedetomidine sedation.
This group will have infraclavicular block and sedation during surgery with intravenous Propofol. Patients will receive intravenous Propofol sedation 50-100 mcg/kg/min infusion. The infusion will be stopped 15 minutes before the end of surgery.
This group will have infraclavicular block and sedation with intravenous Dexmedetomidine. Patients will receive intravenous Dexmedetomidine sedation bolus 0.5mcg/kg in 10 minutes and then 0.2-0.5 mg/kg/hr infusion. The infusion will be stopped 15 minutes before the end of surgery.